Robert M Tanguay Selected Research

Tyrosinemias (Tyrosinemia)

1/2019	Presence of three mutations in the fumarylacetoacetate hydrolase gene in a patient with atypical symptoms of hereditary tyrosinemia type I.
1/2017	Molecular Aspects of the FAH Mutations Involved in HT1 Disease.
10/2016	Identification of circulating microRNAs during the liver neoplastic process in a murine model of hereditary tyrosinemia type 1.
12/2015	Molecular changes associated with chronic liver damage and neoplastic lesions in a murine model of hereditary tyrosinemia type 1.
1/2015	Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1.
4/2014	Heat shock response associated with hepatocarcinogenesis in a murine model of hereditary tyrosinemia type I.
3/2008	Rescue from neonatal death in the murine model of hereditary tyrosinemia by glutathione monoethylester and vitamin C treatment.
5/2006	Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1.
3/2006	Involvement of endoplasmic reticulum stress in hereditary tyrosinemia type I.
11/2004	Cytoplasmic nonsense-mediated mRNA decay for a nonsense (W262X) transcript of the gene responsible for hereditary tyrosinemia, fumarylacetoacetate hydrolase.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert M Tanguay Research Topics

Disease

13	Tyrosinemias (Tyrosinemia) 01/2019 - 10/2003
4	Neoplasms (Cancer) 01/2017 - 06/2004
3	Metabolic Diseases (Metabolic Disease) 12/2015 - 10/2003
3	Coronary Disease (Coronary Heart Disease) 04/2014 - 01/2005
2	Acute Coronary Syndrome 01/2021 - 01/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 10/2016
2	Atherosclerosis 09/2010 - 01/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2017
1	Dystonia musculorum deformans type 1 04/2015
1	Dystonia (Limb Dystonia) 04/2015
1	Liver Diseases (Liver Disease) 04/2014
1	Myocardial Infarction 04/2014
1	Tachycardia (Tachyarrhythmias) 09/2011
1	Unstable Angina 09/2010
1	Lung Neoplasms (Lung Cancer) 05/2009
1	Confusion (Bewilderment) 01/2009
1	Perinatal Death 03/2008
1	Atrial Fibrillation 01/2007
1	Wounds and Injuries (Trauma) 05/2006
1	Body Weight (Weight, Body) 05/2006
1	Chromosomal Instability (Chromosome Stability) 03/2006
1	Occupational Stress 01/2006
1	Multiple Endocrine Neoplasia Type 1 11/2005
1	Asthma (Bronchial Asthma) 02/2005
1	Hypoxia (Hypoxemia) 01/2005
1	Hypertension (High Blood Pressure) 01/2005
1	Cerebral Infarction 09/2004
1	Ischemic Stroke 09/2004
1	Neurologic Manifestations (Neurological Manifestations) 09/2004
1	Pathologic Processes 03/2004
1	Noise-Induced Hearing Loss (Acoustic Trauma) 01/2004
1	Ear Diseases (Disease, Ear) 01/2004
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2004
1	Autoimmune Diseases (Autoimmune Disease) 01/2004

Drug/Important Bio-Agent (IBA)

11	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2014 - 01/2004
10	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 10/2003
9	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 01/2019 - 12/2003
5	EnzymesIBA 01/2017 - 11/2004
5	AntibodiesIBA 01/2006 - 01/2004
3	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2014
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2004
3	Pharmaceutical PreparationsIBA 01/2017 - 09/2011
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 02/2005 - 09/2004
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2017
1	Glutamic Acid (Glutamate)FDA Link 04/2015
1	CalciumIBA 10/2013
1	Annexin A1IBA 10/2013
1	BGP 15IBA 09/2011
1	AntigensIBA 01/2011
1	ImmunosorbentsIBA 09/2010
1	Biomarkers (Surrogate Marker)IBA 05/2009
1	acetoacetic acid (acetoacetate)IBA 03/2008
1	fumarylacetoacetateIBA 03/2008
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2008
1	FumaratesIBA 03/2008
1	Glutathione (Reduced Glutathione)IBA 03/2008
1	Cytostatic AgentsIBA 03/2006
1	Mitogen-Activated Protein KinasesIBA 11/2005
1	Interleukin-4 (Interleukin 4)IBA 02/2005
1	Immunoglobulin E (IgE)IBA 02/2005
1	Crystallins (Crystallin)IBA 01/2005
1	Nonsense Codon (Nonsense Mutation)IBA 11/2004
1	Messenger RNA (mRNA)IBA 11/2004
1	Environmental Pollutants (Pollutants, Environmental)IBA 06/2004
1	Benzo(a)pyreneIBA 06/2004
1	MutagensIBA 06/2004
1	Inosine Triphosphate (ITP)IBA 01/2004
1	Platelet Membrane GlycoproteinsIBA 01/2004
1	AutoantibodiesIBA 01/2004
1	Chaperonin 60IBA 01/2004
1	EpitopesIBA 01/2004

Therapy/Procedure

1	Therapeutics 04/2014